Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Molecular Diagnostics » Natera Outlines Plans for Cancer, Transplant Assays; Provides Update on Legal Proceedings

Natera Outlines Plans for Cancer, Transplant Assays; Provides Update on Legal Proceedings

Nov 12, 2019
|
Julia Karow
Premium

NEW YORK – Natera recently provided updates on the development of its Signatera cancer and Prospera organ transplant assays, both cell-free DNA tests, as well as on a number of legal proceedings it is part of, including three patent lawsuits and two suits filed by patients.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Director of Both, For Now

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

Behind on Testing

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

From CRISPR Lab to COVID-19 Lab

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

Nature Papers Present New CRISPR Screening Approach, Discuss CRISPR in Crop Breeding, More

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. FDA Releases New EUA Guidance for MDx Labs Offering SARS-CoV-2 Testing

  2. Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

  3. Color Gears Up to Enter COVID-19 Testing Space

  4. Nuclein Exits Stealth Mode With Disposable Handheld qPCR System, COVID-19 Test

  5. Qiagen Receives FDA Emergency Use Authorization for SARS-CoV-2 Respiratory Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.